Bachamanda Somesh, Dipthi
Klose, Kristin https://orcid.org/0000-0003-4502-6389
Maring, Janita A.
Kunkel, Désirée
Jürchott, Karsten
Protze, Stephanie I.
Klein, Oliver
Nebrich, Grit
Becker, Matthias
Krüger, Ulrike
Nazari-Shafti, Timo Z.
Falk, Volkmar
Kurtz, Andreas
Gossen, Manfred
Stamm, Christof https://orcid.org/0000-0003-3035-2106
Funding for this research was provided by:
Helmholtz Association (Programme-oriented funding)
German Research Foundation (Through the Berlin‐Brandenburg School for Regenerative Therapies GSC 203)
Charité – Universitätsmedizin Berlin (Doctoral research stipend, Doctoral research stipend)
German Federal Ministry of Education and Research (1315848A, 1315848B, 13GW0098, 13GW0099)
Charité - Universitätsmedizin Berlin
Article History
Received: 24 March 2022
Accepted: 25 September 2023
First Online: 15 October 2023
Declarations
:
: All animal procedures, including surgery, follow-up examinations, and sacrifice, were approved by the State Office of Health and Social Affairs Berlin (wildtype and <i>Myh6</i>-mCherry cell isolation, approval no.: T0158/15, project title: killing notice, approval date: 06-22-2015; C57BL/6 J myocardial infarction model, approval no.: G0288/16, project title: epicardial hybrid patch, approval date: 02-02-2017) and conducted in accordance with the Directive 2010/63/EU of the European Union, the German Animal Welfare Act, and the Charité Animal Welfare Guidelines. The manuscript adheres to the ARRIVE guidelines () for the reporting of animal experiments. Not applicable.
: Not applicable.
: The authors declare no conflict of interest.